Morgan Stanley Kronos Bio, Inc. Transaction History

Morgan Stanley

$1.27 Trillion
Q2 2024

A detailed history of Morgan Stanley transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Morgan Stanley holds 37,837 shares of KRON stock, worth $36,701. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,837

Previous 37,837 -0.0%

Holding current value

$36,701

Previous $49,000 6.12%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Aug 16, 2024	SELL	$1.02 - $1.3 $714 - $910	-700 Reduced 1.82%	37,837 $49,000
Q1 2024 May 15, 2024	SELL	$1.02 - $1.3 $714 - $910	-700 Reduced 1.82%	37,837 $49,000
Q4 2023 Aug 16, 2024	BUY	$0.75 - $1.49 $525 - $1,043	700 Added 1.85%	38,537 $48,000
Q4 2023 Feb 13, 2024	SELL	$0.75 - $1.49 $3,117 - $6,193	-4,157 Reduced 9.74%	38,537 $48,000
Q3 2023 Nov 15, 2023	SELL	$1.23 - $2.25 $64,444 - $117,886	-52,394 Reduced 55.1%	42,694 $55,000
Q2 2023 Aug 14, 2023	SELL	$1.24 - $1.92 $517,093 - $800,661	-417,011 Reduced 81.43%	95,088 $163,000
Q1 2023 May 15, 2023	BUY	$1.34 - $2.62 $70,258 - $137,371	52,432 Added 11.41%	512,099 $747,000
Q4 2022 Feb 14, 2023	BUY	$1.44 - $3.44 $308,184 - $736,218	214,017 Added 87.12%	459,667 $744,000
Q3 2022 Nov 14, 2022	BUY	$3.35 - $5.55 $106,710 - $176,789	31,854 Added 14.9%	245,650 $822,000
Q2 2022 Oct 27, 2022	BUY	$3.12 - $7.52 $18,117 - $43,668	5,807 Added 2.79%	213,796 $778,000
Q2 2022 Aug 15, 2022	BUY	$3.12 - $7.52 $18,117 - $43,668	5,807 Added 2.79%	213,796 $778,000
Q1 2022 Oct 27, 2022	SELL	$6.26 - $14.42 $36,351 - $83,736	-5,807 Reduced 2.72%	207,989 $1.5 Million
Q1 2022 May 13, 2022	BUY	$6.26 - $14.42 $42,737 - $98,445	6,827 Added 3.39%	207,989 $1.5 Million
Q4 2021 Feb 14, 2022	BUY	$11.35 - $21.18 $743,674 - $1.39 Million	65,522 Added 48.31%	201,162 $2.73 Million
Q3 2021 Nov 15, 2021	BUY	$18.17 - $24.7 $2.46 Million - $3.35 Million	135,640 New	135,640 $2.84 Million

Others Institutions Holding KRON

# of Institutions

Shares Held

20.7M

Call Options Held

31.4K

Put Options Held

View Full List

About Kronos Bio, Inc.

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $55.1M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

More about KRON

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account